NCT03122951 is a NA clinical trial of ovulation test use in Trying to Conceive Population, sponsored by SPD Development Company Limited.

Who is sponsoring NCT03122951?

NCT03122951 is sponsored by SPD Development Company Limited.

What drugs are being tested in NCT03122951?

Interventions in NCT03122951: ovulation test use.

What condition does NCT03122951 study?

NCT03122951 studies Trying to Conceive Population.

Is NCT03122951 still recruiting?

NCT03122951 is currently completed. Last updated 9 November 2018.

Last reviewed 2018-11-09 · How we verify

NCT03122951

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clearblue® Advanced Ovulation Test User Study

Completed NA Last updated 9 November 2018

What this trial tests

NA trial testing ovulation test use in Trying to Conceive Population in 577 participants. Completed in 27 October 2017.

Timeline

21 April 2017

Primary endpoint
27 October 2017

27 October 2017

Quick facts

Lead sponsor	SPD Development Company Limited
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	577
Start date	21 April 2017
Primary completion	27 October 2017
Estimated completion	27 October 2017
Sites	1 location across United Kingdom

Drugs / interventions tested

ovulation test use

Conditions studied

Trying to Conceive Population — all drugs for Trying to Conceive Population →

Sponsor

SPD Development Company Limited

Who can join

Adults 18 to 45, female only, with Trying to Conceive Population. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Clearblue® Advanced Ovulation Test is designed for home use by women who are either planning or trying for a pregnancy. The purpose of this protocol is to demonstrate that lay-users representative of the target user population are able to use the product in the intended user environment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other SPD Development Company Limited trials

Trials by the same sponsor.

NCT06171373 — Extension for Menopause Sample Collection · completed
NCT05091658 — Period Tracker Lay User Study · completed
NCT05088382 — Period Tracker at Home Study · completed
NCT04853472 — Menopause Sample Collection · completed
NCT04756739 — Menstrual Cycle Symptom Tracking · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03122951 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by SPD Development Company Limited
Last refreshed: 9 November 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03122951.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing